Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,970 followers.

https://t.co/OBzKtPmJCp

26 Dec 2023

Reply Repost Favourite

New Research: Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study: Background We compared the real-world efficacy and safety of neoadjuvant… https://t.co/grpULd

22 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.